Mirvetuximab
Product Specifications
CAS Number
1453084-36-0
Target
Antifolate, ADC Antibody
Related Pathways
Antibody-drug Conjugate/ADC Related, Cell Cycle/Checkpoint
Purity
>95%
Bioactivity
Mirvetuximab (M9346A) is a novel folate receptor α (FRα) monoclonal antibody targeting anti-FOLR1 (folate receptor 1) . Mirvetuximab soravtansine is often conjugated with platinum compounds or other compounds to form antibody-drug conjugates for the treatment of ovarian cancer and other FRα-positive cancers.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog